PRO Consortium
News & Events
- September 13, 2019
-
September 6, 2018
Response scale selection in adult pain measures: results from a literature review
Safikhani S, Gries K, Trudeau JJ, Reasner D, Rudell K, Coons SJ, et al. Response scale selection in adult pain measures: results from a literature review. Journal of Patient-Reported Outcomes. 2018;2:40.
-
September 6, 2018
Literature review to characterize the empirical basis for response scale selection in pediatric populations
Naegeli AN, Hanlon J, Gries KS, Safikhani S, Ryden A, Patel M, et al. Literature review to characterize the empirical basis for response scale selection in pediatric populations. Journal of Patient-Reported Outcomes. 2018;2:39.
-
September 6, 2018
Literature review to assemble the evidence for response scales used in patient-reported outcome measures
Gries K, Berry P, Harrington M, Crescioni M, Patel M, Rudell K, et al. Literature review to assemble the evidence for response scales used in patient-reported outcome measures. Journal of Patient-Reported Outcomes. 2018;2:41.
-
June 1, 2018
Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero M, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O’Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop. Value in Health 2018;21:742-747.